metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter ty...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors
Cetoacidosis diabética euglucémica asociada a los inhibidores del cotransportador sodio-glucosa tipo 2
Íñigo Isern de Val
Corresponding author
inigoisern@gmail.com

Corresponding author.
, Héctor Mercado Castillo, María del Carmen Díaz Melé
Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
Read
63
Times
was read the article
2
Total PDF
61
Total HTML
Share statistics
 array:24 [
  "pii" => "S2387020624002778"
  "issn" => "23870206"
  "doi" => "10.1016/j.medcle.2024.01.024"
  "estado" => "S300"
  "fechaPublicacion" => "2024-07-26"
  "aid" => "6601"
  "copyright" => "Elsevier España, S.L.U.. All rights reserved"
  "copyrightAnyo" => "2024"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Med Clin. 2024;163:101-2"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0025775324001623"
      "issn" => "00257753"
      "doi" => "10.1016/j.medcli.2024.01.025"
      "estado" => "S300"
      "fechaPublicacion" => "2024-07-26"
      "aid" => "6601"
      "copyright" => "Elsevier España, S.L.U."
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Med Clin. 2024;163:101-2"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>"
        "titulo" => "Cetoacidosis diab&#233;tica eugluc&#233;mica asociada a los inhibidores del cotransportador sodio-glucosa tipo 2"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "101"
            "paginaFinal" => "102"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "&#205;&#241;igo Isern de Val, H&#233;ctor Mercado Castillo, Mar&#237;a del Carmen D&#237;az Mel&#233;"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "&#205;&#241;igo"
                "apellidos" => "Isern de Val"
              ]
              1 => array:2 [
                "nombre" => "H&#233;ctor"
                "apellidos" => "Mercado Castillo"
              ]
              2 => array:2 [
                "nombre" => "Mar&#237;a del Carmen"
                "apellidos" => "D&#237;az Mel&#233;"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2387020624002778"
          "doi" => "10.1016/j.medcle.2024.01.024"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624002778?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775324001623?idApp=UINPBA00004N"
      "url" => "/00257753/0000016300000002/v1_202407151339/S0025775324001623/v1_202407151339/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2387020624002894"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2024.01.029"
    "estado" => "S300"
    "fechaPublicacion" => "2024-07-26"
    "aid" => "6606"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Med Clin. 2024;163:102-4"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Post-infantile giant cell hepatitis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "102"
          "paginaFinal" => "104"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Hepatitis de c&#233;lulas gigantes post-infantil"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1570
              "Ancho" => 3175
              "Tamanyo" => 981182
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Liver biopsy histopathological examination&#58; &#40;a&#41; Liver parenchyma with regenerative nodules with multinucleated giant hepatocytes &#40;arrows&#41;&#44; mainly in periseptal zones &#40;H&#38;E&#44; 10&#215;&#41;&#59; &#40;b&#41; Masson&#39;s trichrome staining highlighting septal fibrosis &#40;arrowheads&#41;&#44; demarcating regenerative nodules&#44; consistent with definitive cirrhosis &#40;Ishak score 6&#41;&#59; &#40;c&#41; Presence of septal and intralobular lymphocyte-predominant inflammatory infiltrate &#40;arrows&#41; and focal hepatocellular necrosis &#40;dashed circle&#41; &#40;H&#38;E&#44; 100&#215;&#41;&#59; &#40;d&#41; Multinucleated giant hepatocytes &#40;arrows&#41; and mild interface hepatitis &#40;asterisk&#41; &#40;H&#38;E&#44; 200&#215;&#41;&#59; &#40;e&#41; Multinucleated giant hepatocytes &#40;arrows&#41;&#44; having more than 4&#8211;5 nuclei&#44; and the aforementioned features of hepatitis&#44; allowing the diagnosis of PIGCH&#46; Eosinophils are also noted &#40;arrowhead&#41; &#40;H&#38;E&#44; 400&#215;&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "In&#234;s Costa Santos, Cl&#225;udio Martins, Ana Lu&#237;sa Alves"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "In&#234;s"
              "apellidos" => "Costa Santos"
            ]
            1 => array:2 [
              "nombre" => "Cl&#225;udio"
              "apellidos" => "Martins"
            ]
            2 => array:2 [
              "nombre" => "Ana Lu&#237;sa"
              "apellidos" => "Alves"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624002894?idApp=UINPBA00004N"
    "url" => "/23870206/0000016300000002/v1_202407220832/S2387020624002894/v1_202407220832/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2387020624002833"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2024.01.027"
    "estado" => "S300"
    "fechaPublicacion" => "2024-07-26"
    "aid" => "6591"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Med Clin. 2024;163:100-1"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Bilateral endophthalmitis secondary to endocarditis due to <span class="elsevierStyleItalic">Aggregatibacter actinomycetemcomitans</span>"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "100"
          "paginaFinal" => "101"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Endoftalmitis bilateral secundaria a endocarditis por <span class="elsevierStyleItalic">Aggregatibacter actinomycetemcomitans</span>"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1125
              "Ancho" => 2925
              "Tamanyo" => 329773
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Figure "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#46; Ultrasound image of the right eye&#44; showing dense intermediate uveitis &#40;&#42;&#41;&#46; B&#46; Echocardiographic image obtained by transoesophageal echocardiography&#44; showing the presence of an infectious wart on the mitral valve of 12&#8239;mm with signs of associated severe regurgitation &#40;arrow&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "V&#237;ctor Mallen Gracia, Elena Oliver Garc&#237;a, Jacobo Y&#225;&#241;ez Merino"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "V&#237;ctor"
              "apellidos" => "Mallen Gracia"
            ]
            1 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Oliver Garc&#237;a"
            ]
            2 => array:2 [
              "nombre" => "Jacobo"
              "apellidos" => "Y&#225;&#241;ez Merino"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S002577532400143X"
        "doi" => "10.1016/j.medcli.2024.01.021"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577532400143X?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624002833?idApp=UINPBA00004N"
    "url" => "/23870206/0000016300000002/v1_202407220832/S2387020624002833/v1_202407220832/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
    "titulo" => "Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Dear Editor&#44;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "101"
        "paginaFinal" => "102"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "&#205;&#241;igo Isern de Val, H&#233;ctor Mercado Castillo, Mar&#237;a del Carmen D&#237;az Mel&#233;"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "&#205;&#241;igo"
            "apellidos" => "Isern de Val"
            "email" => array:1 [
              0 => "inigoisern@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "H&#233;ctor"
            "apellidos" => "Mercado Castillo"
          ]
          2 => array:2 [
            "nombre" => "Mar&#237;a del Carmen"
            "apellidos" => "D&#237;az Mel&#233;"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Hospital Cl&#237;nico Universitario Lozano Blesa&#44; Zaragoza&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Cetoacidosis diab&#233;tica eugluc&#233;mica asociada a los inhibidores del cotransportador sodio-glucosa tipo 2"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Euglycemic diabetic ketoacidosis &#40;EDKA&#41; is a rare but potentially serious complication of sodium-glucose cotransporter type 2 inhibitors &#40;SGLT-2i&#41;&#44; which can lead to ketoacidosis without a significant increase in blood glucose levels&#46; Its approach involves correction of acid-base and electrolyte imbalances together with intensive insulin therapy&#46; In some cases&#44; also dialysis&#46; The present case highlights the importance of considering EDKA as a possible side effect in patients receiving this medication&#44; especially in situations of metabolic stress&#46; Disclosure of the presence of this entity may be crucial to avoid diagnostic delay&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The following is a case report of a 42-year-old female patient with hypertension&#44; hypercholesterolaemia&#44; obesity and type 2 diabetes mellitus&#44; treated with metformin and empagliflozin&#44; an SGLT-2i&#46; She underwent gastric bypass surgery seven days before the episode&#44; with no immediate complications&#46; The patient was discharged after four days to continue her recovery&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">However&#44; the next day&#44; the patient started with abdominal pain&#44; polyuria and general malaise&#44; along with disorientation&#46; She went to the emergency department&#44; where severe metabolic acidosis was observed with a pH of 6&#46;95 and a bicarbonate &#40;HCO3&#41; of 7&#46;1&#8239;mmol&#47;L&#44; although lactate levels were in the normal range &#40;1&#46;2&#8239;mmol&#47;L&#41;&#46; In addition&#44; she had leukocytosis of 20&#44;000&#47;mm<span class="elsevierStyleSup">3</span>&#44; with normal blood glucose levels&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">To rule out postoperative complications&#44; an abdominopelvic computed tomography &#40;CT&#41; scan was performed&#44; with no significant findings&#46; Despite a total of 250&#8239;mmol of sodium bicarbonate&#44; there was no improvement&#46; Due to muscle exhaustion&#44; tachypnoea and shallow breathing&#44; the patient was intubated and connected to invasive mechanical ventilation&#46; The patient was subsequently transferred to Intensive Care Medicine &#40;ICM&#41;&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">A repeat contrast-enhanced chest-abdomen-pelvis CT scan was performed with no further complications&#46; Toxicological tests&#44; including metformin and paracetamol&#44; were also performed&#46; Despite these measures&#44; the patient continued to present with severe acidosis&#44; hypernatremia and hypokalaemia&#44; with lactate in range&#44; elevated anion GAP of 39&#8239;mmol&#47;L&#46; As a result&#44; she was urgently dialysed&#46; The clinical suspicion was confirmed by the presence of glycosuria and ketonuria&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The clinical signs were consistent with EDKA&#44; as a consequence of empagliflozin &#40;SGLT2i&#41; administration and surgical metabolic stress&#44; as well as decreased intake&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">She was started on rapid intravenous insulin at 6 IU&#47;h and 5&#37; glucose IV hydration therapy was implemented&#46; A progressive correction of acid-base balance and electrolyte imbalances was observed through adequate intake&#46; Despite this&#44; ketone bodies in the urine persisted&#44; so intensive insulin therapy was continued&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">On the fourth day of hospitalisation&#44; the weaning process was started and the patient was extubated without complications&#46; An oral diet was started&#44; which was well tolerated&#44; and the patient was discharged from the Intensive Care Unit &#40;ICU&#41;&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">EDKA is rare but is on the rise since the approval of SGLT2i in 2013&#46; These drugs&#44; empagliflozin&#44; canagliflozin and dapagliflozin&#44; are used in the treatment of both diabetes and heart failure&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#8211;3</span></a> Although most patients who receive them do not develop complications&#44; EDKA is considered a serious side effect&#44; and its aetiology is multifactorial&#46;<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2&#44;3</span></a> It requires precipitating factors such as acute illness&#44; surgery&#44; fasting&#44; dehydration&#44; reduced intake&#44; among others&#46; Ultimately&#44; any condition that significantly increases ketosis&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#8211;3</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">SGLT2i reduces plasma glucose by inhibiting the sodium-glucose cotransporter-2 in the proximal renal tubule&#44; leading to the elimination of 50&#8211;80&#8239;g of glucose per day&#46; Insulin secretion decreases and glucagon release increases&#44; promoting lipolysis and ketogenesis&#46; In addition&#44; the reabsorption of ketone bodies in the renal tubular system is increased&#46;<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2&#44;4&#44;5</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">EDKA&#44; characterised by blood glucose levels in the normal range&#44; may go unrecognised&#44; delaying diagnosis and treatment&#46; Significant ketoacidosis with normal lactate&#44; highly increased anion GAP&#44; normal or near-normal blood glucose and ketone bodies in blood and urine are some of its signs&#46; It may progress to severe ketoacidosis with encephalopathy and coma&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#8211;5</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">Although there are no specific guidelines&#44; the treatment of EDKA is based on volume replacement and insulin therapy&#44; ensuring adequate potassium and glucose levels by administering glucose saline&#46; Sodium bicarbonate replacement is an option in cases of severe acidosis&#46; The prognosis is favourable when treatment is initiated&#44; however&#44; diagnostic delay can be fatal&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#8211;5</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">Given the increasing use of SGLT2i due to its benefits in diabetes mellitus and its cardiovascular and renal effects&#44; it is essential to increase diagnostic suspicion and awareness of EDKA&#46; Dissemination of this clinical entity will contribute to early detection and treatment&#44; especially in the emergency and intensive care settings&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Ethical considerations</span><p id="par0070" class="elsevierStylePara elsevierViewall">This work has not involved experiments&#46; Medical records were accessed with appropriate permission&#46; Individuals&#39; privacy rights were safeguarded&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Funding</span><p id="par0075" class="elsevierStylePara elsevierViewall">This work has not received any funding&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflict of interest</span><p id="par0080" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:4 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Ethical considerations"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Funding"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflict of interest"
        ]
        3 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Euglycemic diabetic ketoacidosis associated with the use of a sodium&#8211;glucose cotransporter-2 inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46; Zhang"
                            1 => "M&#46; Tamilia"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1503/cmaj.171319"
                      "Revista" => array:5 [
                        "tituloSerie" => "Can Med Assoc J"
                        "fecha" => "2018"
                        "volumen" => "190"
                        "paginaInicial" => "E766"
                        "paginaFinal" => "E768"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin&#58; case report and literature review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Sampani"
                            1 => "P&#46; Sarafidis"
                            2 => "C&#46; Dimitriadis"
                            3 => "E&#46; Kasimatis"
                            4 => "D&#46; Daikidou"
                            5 => "K&#46; Bantis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s12882-020-01930-6"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMC Nephrol"
                        "fecha" => "2020"
                        "volumen" => "21"
                        "paginaInicial" => "276"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32669085"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SGLT2 Inhibitors and Euglycemic Ketoacidosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "P&#46; Masuta"
                            1 => "G&#46; Johri"
                            2 => "M&#46; Paul"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MJT.0000000000000587"
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J Ther"
                        "fecha" => "2018"
                        "volumen" => "25"
                        "paginaInicial" => "e498"
                        "paginaFinal" => "e500"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Euglycemic Ketoacidosis With Sodium&#8211;Glucose Cotransporter-2 Inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;A&#46; Koch"
                            1 => "R&#46;F&#46; Clark"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MJT.0000000000000602"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Ther"
                        "fecha" => "2018"
                        "volumen" => "25"
                        "paginaInicial" => "e590"
                        "paginaFinal" => "e591"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28452848"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "G&#46; Velasco de Cos"
                            1 => "M&#46;I&#46; S&#225;nchez-Molina Acosta"
                            2 => "M&#46;M&#46;T&#46; Fern&#225;ndez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "EJIFCC"
                        "fecha" => "2021"
                        "volumen" => "32"
                        "paginaInicial" => "105"
                        "paginaFinal" => "110"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33753980"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23870206/0000016300000002/v1_202407220832/S2387020624002778/v1_202407220832/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "43309"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23870206/0000016300000002/v1_202407220832/S2387020624002778/v1_202407220832/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624002778?idApp=UINPBA00004N"
]
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 October 15 0 15
2024 September 19 2 21
2024 August 21 0 21
2024 July 6 0 6

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos